Allergan Inc
AGN
AGN was delisted on the 16th of March, 2015.
9 hedge funds and large institutions have $3.48M invested in Allergan Inc in 2019 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.
8% less capital invested
Capital invested by funds: $3.77M → $3.48M (-$288K)
10% less funds holding
Funds holding: 10 → 9 (-1)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIM
Sonora Investment Management
Tucson,
Arizona
|
+$52K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CA
Callahan Advisors
Houston,
Texas
|
-$452K |
| 2 |
CAM
Cubic Asset Management
Boston,
Massachusetts
|
-$310K |
| 3 |
MMPW
Mitchell McLeod Pugh & Williams
Mobile,
Alabama
|
-$70K |
| 4 |
GAM
Gemmer Asset Management
Walnut Creek,
California
|
-$4.8K |
AGN Hedge Fund Activity: Q2 2019 in Review
9 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Allergan Inc (AGN) for Q2 2019, worth a combined $3.48M — down 7.6% from $3.77M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of AGN and 0 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 1 added.
The largest buyer was Sonora Investment Management, adding an estimated $52K. The largest seller was Callahan Advisors, cutting an estimated $452K.
- 9 institutional investors held Allergan Inc (AGN) as of Q2 2019, down from 10 in Q1 2019.
- Funds reported $3.48M of Allergan Inc stock for Q2 2019, down 7.6% quarter-over-quarter.
- 0 funds opened new Allergan Inc positions in Q2 2019 and 1 closed out, a net change of -1 holder.
- The largest Allergan Inc buyer in Q2 2019 was Sonora Investment Management, an estimated $52K added.
- The largest Allergan Inc seller in Q2 2019 was Callahan Advisors, an estimated $452K sold.
Based on aggregated 13F filings for Q2 2019.